[EN] BENZIMIDAZOLE DERIVATIVES AS ITK INHIBITORS<br/>[FR] DÉRIVÉS DE BENZIMIDAZOLE EN TANT QU'INHIBITEURS D'ITK
申请人:PRINCIPIA BIOPHARMA INC
公开号:WO2014036016A1
公开(公告)日:2014-03-06
The present disclosure is directed to certain inhibitors of kinases such as ITK, BLK, BMX, BTK, JAK3, TEC, TXK, HER2 (ERBB2), or HER4 (ERBB4), in particular ITK, pharmaceutical compositions comprising such compounds, and method of treating diseases mediated by such kinases.
本公开涉及特定激酶抑制剂,如ITK、BLK、BMX、BTK、JAK3、TEC、TXK、HER2(ERBB2)或HER4(ERBB4),特别是ITK,包括这些化合物的药物组合物,以及治疗由这些激酶介导的疾病的方法。